XML 93 R75.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Exercised, aggregate intrinsic value $ 5,079    
Shares underlying options (in shares) 6,999,669 6,011,349 5,488,207
Exercise Price (in USD per share) $ 20.22 $ 19.34 $ 19.37
Remaining contractual term, exercisable (in years) 4 years 7 months 13 days 5 years 1 month 28 days 5 years 4 months 9 days
Exercisable, aggregate intrinsic value $ 21,806 $ 71,063 $ 46,626
Closing stock price of stock options outstanding and exercisable (in USD per share) $ 21.03 $ 31.04 $ 27.25
Stock Options      
Shares      
Outstanding, beginning balance (in shares) 8,886,284    
Granted (in shares) 1,746,270    
Forfeited and expired (in shares) (325,286)    
Exercised (in shares) (374,846)    
Outstanding, ending balance (in shares) 9,932,422 8,886,284  
Vested and expected to vest (in shares) 9,932,422    
Weighted Average Exercise Price      
Outstanding, beginning balance (in USD per share) $ 20.26    
Granted (in USD per share) 26.76    
Forfeited and expired (in dollars per share) 24.63    
Exercised (in USD per share) 12.23    
Outstanding, ending balance (in USD per share) 21.56 $ 20.26  
Vested and expected to vest (in USD per share) $ 21.56    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Remaining contractual term, outstanding (in years) 5 years 9 months 14 days 6 years 3 months 7 days  
Vested and expected to vest (in years) 5 years 9 months 14 days    
Outstanding, aggregate intrinsic value $ 24,658 $ 96,577  
Exercised, aggregate intrinsic value 5,100 $ 7,500 $ 1,800
Vested and expected to vest value $ 24,658    
Weighted average grant date fair value of options (in USD per share) $ 13.45 $ 14.00 $ 9.54
Compensation expense not yet recognized, stock options $ 31,900    
Weighted average period for unrecognized costs (in years) 2 years 6 months    
Expiration Term 10 years    
Stock Options | Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Expiration Term 10 years    
Modification expense $ 3,200